Mitochondrial energy metabolism produces ATP to support cellular activities at the same time that superoxide, the byproduct of electron transport, can either trigger signaling responses or post threats to cellular functions. Conserved superoxide dismutase (SOD) functions in protection by scavenging superoxide and converting to H2O2. Eliminating mitochondrial SODs causes neonatal/embryonic lethality in both mice and flies, but not in the nematode C. elegans. C. elegans have 2 mitochondrial sod genes (
sod-2 and
sod-3) while mice and flies have one. Eliminating mitochondrial
sod-2 can actually increase C. elegans lifespan. The mechanism causing C. elegans to be resistant to mitochondrial superoxide stress is still unknown. A metabolic pathway, named glyoxylate shunt, distinguishes C. elegans from mice and flies. As an alternative branch to the tricarboxylic acid (TCA) cycle, the glyoxylate shunt is missing in both mice and flies. The
icl-1 isocitrate lyase gene encodes the key enzymes of the glyoxylate shunt in C. elegans. We found that
icl-1 is critical for protection against embryonic lethality when mitochondrial SODs are absent. The mitochondrial
sod-2;
sod-3 double mutant exhibits embryonic lethality in the range of 5% to 9%, which is associated with elevated
icl-1 gene expression. We crossed the
sod-2;
sod-3 mutant to an
icl-1 null allele,
icl-1(
ok531), and found that the embryonic lethality rose to ~ 60%. Thus,
icl-1 protects against embryonic lethality in the absence of mitochondrial SOD. To explore the mechanism by which
icl-1 protects against embryonic lethality, we examined its role in activating the mitochondrial unfolded protein response (UPRmt). We found that
icl-1 is required for the efficient activation of the UPRmt and the UPRmt is required to suppress embryonic/neonatal lethality. We also found that the UPRmt plays a significant role in protecting against mitochondrial superoxide stress, as the constitutive activation of UPRmt via
atfs-1(gf)can bypass the
icl-1 requirement. Our study reveals a pathway that involves the C. elegans specific glyoxylate shunt and a much-conserved UPRmt to counteract mitochondrial superoxide stress. This pathway might be manipulated in developing synthetic biological tools or innovative pharmacological methods to treat diseases that are related to mitochondrial superoxide stress.